Projects per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Research Interest Keywords
- Oncology
- Health Outcomes
- Early phase clinical development
- pharmacogenetics and pharmacogenomics
- Clinical Pharmacology
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
Identification and Characterization of Patients with Desmoid Tumor and the Associated Epidemiology in the US
Stenehjem, D. D. (PI)
8/15/23 → 6/30/25
Project: Research project
-
Steady-state pharmacokinetics of osimertinib stratified by CYP1A2 and CYP2D6 genotypes
Brown, J. T. (PI) & Stenehjem, D. D. (CoI)
Whiteside Inst. for Clinical Research
1/1/20 → 12/31/25
Project: Research project
-
Identifying Treatment and Testing Disparities in Metastatic Breast Cancer to Improve Treatment Pathways and Outcomes
Stenehjem, D. D. (PI)
THE UNIVERSITY OF UTAH, ASTRAZENECA
5/3/23 → 12/31/24
Project: Research project
-
Evaluation of HER2-Low Advanced Breast Cancer: A Multicentered Descriptive Study
Stenehjem, D. D. (PI)
THE UNIVERSITY OF UTAH, ASTRAZENECA
1/1/23 → 6/30/23
Project: Research project
-
Clinical characteristics and treatment patterns of patients with NTRK fusion-positive solid tumors: A multisite cohort study at US academic cancer centers
Willis, C., Au, T., Hejazi, A., Griswold, C., Schabath, M. B., Thompson, J., Malhotra, J., Federman, N., Ko, G., Appukkuttan, S., Warnock, N., Kong, S. X., Hocum, B., Brixner, D. & Stenehjem, D., Jul 2024, In: Journal of Managed Care and Specialty Pharmacy. 30, 7, p. 672-683 12 p.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
Modeling the population health impact of incorporating a multi-cancer early detection (MCED) test to existing cancer screening among immunocompromised individuals
Tan, C. J., Ilham, S., Willis, C., Kim, A., Cong, Z., Brixner, D. & Stenehjem, D., 2024, In: Current Medical Research and Opinion. 40, 9, p. 1577-1587 11 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Patient characteristics and treatment patterns of patients with locally advanced or metastatic HER2-low breast cancer, a single site descriptive study
Willis, C., Tan, C. J., Chhibber, A., Watanabe, A. H., Lam, C., Mehta, S., Kwong, J., Park, L., Pavilack-Kirker, M., Xu, X., Kelley, K. & Stenehjem, D., Dec 2024, In: Breast Cancer Research and Treatment. 208, 3, p. 619-630 12 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Patient-reported frailty phenotype (PRFP) vs. International Myeloma Working Group frailty index (IMWG FI) proxy: A comparison between two approaches to measuring frailty
Murugappan, M. N., King-Kallimanis, B. L., Bhatnagar, V., Kanapuru, B., Farley, J. F., Seifert, R. D., Stenehjem, D. D., Chen, T. Y., Horodniceanu, E. G. & Kluetz, P. G., Mar 2024, In: Journal of Geriatric Oncology. 15, 2, 101681.Research output: Contribution to journal › Article › peer-review
Open Access4 Scopus citations -
Adverse event costs associated with first-line therapy for advanced non–small cell lung cancer in the United States: An analysis of clinical trials of immune checkpoint inhibitors
Stenehjem, D., Lubinga, S. J., Wu, A. & Betts, K. A., Sep 2023, In: Journal of Managed Care and Specialty Pharmacy. 29, 9, p. 1054-1064 11 p.Research output: Contribution to journal › Article › peer-review
Open Access